The Future of AI in Pharma, Diagnostics & Precision Medicine | Bill Taranto, President and Founding Partner & Dr. David Rubin, Managing Director - Merck Global Health Innovation Fund

Episode notes

Send us Fan Mail Over the last several years, artificial intelligence has transformed from a speculative concept in healthcare into one of the most heavily funded movements in pharmaceutical and biotech history. But in 2026, the conversation is changing. The question is no longer whether AI can generate molecules, analyze pathology slides, or identify patterns in clinical data. The real question is: which of these technologies can survive the complexity of biology, regulatory scrutiny, clinical validation, and real-world deployment? Today we’re joined once again by returning guest Bill Taranto, President and Founding Partner of the Merck Global Health Innovation Fund ( ), alongside Managing Director, Dr. David Rubin, who brings a deep scientific background spanning molecular biology, oncology, precision medicine, and digital health investing. Together, Bill and David sit at a unique intersection of pharma strategy, venture investing, translational science, and clinical deployment.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Michelle Gill: AI-Assisted Drug Discovery, NVIDIA, Biofoundation Models, Creating Applied Research Teams | Learning from Machine Learning #8Learning from Machine Learning · on Drug Discovery88 / 100
• The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on Biotech81 / 100
• The Evolution and Impact of AI and Machine Learning Across IndustriesBeyond the Screen · on Artificial intelligence79 / 100
• The Frontier State of Nonprofit AcceleratorsThe Frontier State Podcast · on Biotech78 / 100
• World's Leading Safe AI Expert: Superintelligence Will Change Everything & It's Closer Than You Think! - Dr. Craig A. KaplanFour Fs Podcast · on Artificial intelligence74 / 100
• 101: Rapid Transformation - AI, Psychedelics & Leadership with Dr Catriona WallaceHabits of Leadership · on Artificial intelligence73 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences